Supplementary Table 2 from Targeting CD44 Variant 5 with an Antibody–Drug Conjugate Is an Effective Therapeutic Strategy for Intrahepatic Cholangiocarcinoma

Supplementary Table 2 from Targeting CD44 Variant 5 with an Antibody–Drug Conjugate Is an Effective Therapeutic Strategy for Intrahepatic Cholangiocarcinoma

<p>amino acid sequences of mAbs in this study</p>

Na minha lista:
Detalhes bibliográficos
Autor principal: Yuncheng Bei (16546095) (author)
Outros Autores: Jian He (16546098) (author), Xuhui Dong (16546101) (author), Yuxin Wang (16546104) (author), Sijie Wang (16546107) (author), Wan Guo (16546110) (author), Chengjie Cai (16546113) (author), Zhiye Xu (16546116) (author), Jia Wei (11469308) (author), Baorui Liu (15134681) (author), Nan Zhang (16546119) (author), Pingping Shen (16546122) (author)
Publicado em: 2025
Assuntos:
Cancer
Therapeutic Research and Development
Methods and Technology
Biological Agents & Therapies
Antibody-drug conjugates
Computational Methods
Database resources
Drug Targets
Cell surface receptor drug targets
Preclinical Models
Xenograft models
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados

Registos relacionados